Loretta J. Nastoupil, MD, MD Anderson Cancer Center
Advertisement
Articles by Loretta J. Nastoupil, MD, MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Latest in Myeloma, Prostate Cancer, and Lymphoma From ASCO 2021: Drs Neal Shore, Loretta Nastoupil, and Sandy WongPublished: June 9th 2021 | Updated:
Dr. Nastoupil on Future Treatment Approaches in Large Cell LymphomaPublished: October 29th 2016 | Updated:
Dr. Nastoupil on Triplet of TGR1202, Ublituximab, and Ibrutinib in CLLPublished: August 10th 2017 | Updated:
Dr. Nastoupil on Questions Surrounding TGR1202 in Patients With CLLPublished: August 21st 2017 | Updated:
Dr. Nastoupil on Efficacy With Pembrolizumab and Rituximab in Follicular LymphomaPublished: August 28th 2017 | Updated:
Dr. Nastoupil on Pembrolizumab Plus Rituximab in Relapsed Follicular LymphomaPublished: June 15th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5